5.8703.14% ( -0.190 )
Delay Closed: Nov 13, 16:08:17Valuation
Current ValuationThe current P/E ratio is -103.84, within the reasonable range, cheaper than 41.54% of the time in the past 1 years, and the industry ranks 15/15, the industry Median 12.87.
-103.84xP/E
HK$5.87Stock price
HK$-0.06Earnings per share
-103.84xP/E
Stock priceHK$5.87Earnings per shareHK$-0.06
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -114.58x
- Typical range
- -199.41x–249.71x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.87x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.87x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01548HKGENSCRIPT BIO | -13.90x | 102.62% | HK$69.39B |
03347HKTIGERMED | -66.80x | -- | HK$31.49B |
02228HKXTALPI | -103.84x | 167.69% | HK$25.22B |
03696HKINSILICO | -9.52x | 100.56% | HK$22.21B |
02576HKTAIMEI TECH | -33.29x | -- | HK$2.50B |
08225HKC HEALTH GP | -3.66x | -- | HK$59.72M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
